|Bid||2.6000 x 4000|
|Ask||2.6100 x 4000|
|Day's Range||2.5400 - 2.6200|
|52 Week Range||1.0800 - 4.6700|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.50|
A look at the shareholders of Verastem, Inc. ( NASDAQ:VSTM ) can tell us which group is most powerful. Institutions...
In this article we will take a look at the 10 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical industry’s outlook for 2021 and some of the major growth catalysts for pharma stocks and go directly to 5 Best Pharma Stocks to Buy Now. As value stocks begin […]
Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today reported financial results for the three months and full year ending December 31, 2020, and highlighted its key corporate objectives for 2021 and early 2022.